Showing results (661-670 of 749) with videos related to
Sort By:
Pageof 75
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 26, 2022
Patient preferences for lifestyle behaviours in osteoporotic fracture prevention: a cross-European discrete choice experimentC Beaudart, A Boonen, N Li, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 6, 2011
Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?N B Watts, C Roux, J F Modlin, et al.Current Osteoporosis Reports|September 10, 2024
The Fracture Phenotypes in Women and Men of 50 Years and Older with a Recent Clinical FractureP Geusens, J van den Bergh, C Roux, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 7, 2011
Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosisC Roux, D M Reid, J-P Devogelaer, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1997
Effects of cyclical etidronate therapy on bone loss in early postmenopausal women who are not undergoing hormonal replacement therapyJ M Pouilles, F Tremollieres, C Roux, et al.Annals of the Rheumatic Diseases|July 16, 2003
Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countriesA Boonen, D van der Heijde, R Landewé, et al.Arthritis and Rheumatism|May 28, 2010
Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registryJ-E Gottenberg, P Ravaud, T Bardin, et al.Annals of the Rheumatic Diseases|September 10, 2013
Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 studyR Landewé, J Braun, A Deodhar, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 7, 2018
Vertebral fractures cascade: potential causes and risk factorsH Che, V Breuil, B Cortet, et al.Arthritis Care & Research|June 8, 2012
Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational studyF Tubach, P Ravaud, E Martin-Mola, et al.Pageof 75